GENELUX Corp SEC filings GNLX
GENELUX Corp has 359 filings in SEC EDGAR's recent list, going back to May 5, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 22, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Feb 13, 2024 | — |
| CORRESP | Letter to the SEC | Feb 8, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2024 | — |
| EFFECT | Filing | Jul 3, 2023 | — |
| CORRESP | Letter to the SEC | Jun 29, 2023 | — |
| D | Filing | Jun 29, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2023 | — |
| D | Filing | Jun 15, 2023 | — |
| SEC STAFF LETTER | Filing | Jan 26, 2023 | — |
| CERT | Filing | Jan 26, 2023 | — |
| EFFECT | Filing | Jan 25, 2023 | — |
| 8-A12B | Filing | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Nov 4, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| SEC STAFF LETTER | Filing | Sep 8, 2022 | — |
| CORRESP | Letter to the SEC | Aug 29, 2022 | — |
| CORRESP | Letter to the SEC | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2022 | — |
| DRSLTR | Filing | May 20, 2022 | — |
| DRS/A | Filing | May 20, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2021 | — |
| DRSLTR | Filing | Jun 24, 2021 | — |
| DRS/A | Filing | Jun 24, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2021 | — |
| DRS | Filing | May 7, 2021 | — |
| D | Filing | Jun 6, 2012 | — |
| D | Filing | Jul 9, 2010 | — |
| D | Filing | Apr 9, 2009 | — |
| REGDEX | Auto-generated paper document | Nov 12, 2008 | — |
| REGDEX | Auto-generated paper document | Nov 8, 2007 | — |
| REGDEX | Auto-generated paper document | Dec 1, 2006 | — |
| REGDEX | Auto-generated paper document | Nov 1, 2005 | — |
| REGDEX/A | Auto-generated paper document | Nov 22, 2004 | — |
| REGDEX | Auto-generated paper document | Jul 23, 2004 | — |
| REGDEX | Auto-generated paper document | May 5, 2003 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GNLX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1231457
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.